By Devika Patel
Knoxville, Tenn., Sept. 5 – Pfizer Inc. offered further details about a $5 billion sale of senior notes (A1/AA/A+) that priced in six tranches on Tuesday, according to an FWP filed with the Securities and Exchange Commission.
Pfizer priced $1 billion of 3% three-year notes at a spread of Treasuries plus 32 basis points. These notes priced at 99.865 to yield 3.047%.
The company sold $300 million of five-year floating-rate notes at Libor plus 33 bps. These notes priced at par.
A $1 billion tranche of 3.2% five-year fixed-rate notes priced at a 47 bps over Treasuries spread. These notes priced at 99.797 to yield 3.244%.
Pfizer priced $1 billion of 3.6% 10-year notes at a spread of 72 bps over Treasuries. These notes priced at 99.841 to yield 3.619%.
The company sold $700 million of 4.1% 20-year notes at a 105 bps spread over Treasuries. These notes priced at 99.809 to yield 4.114%.
In the final tranche, Pfizer priced $1 billion of 4.2% 30-year notes at a spread of 115 bps over Treasuries. These notes priced at 99.762 to yield 4.214%.
BofA Merrill Lynch, Citigroup Global Markets Inc., Credit Suisse Securities (USA) LLC and Morgan Stanley & Co. LLC were the active bookrunners. Barclays, Goldman Sachs & Co. and HSBC Securities (USA) Inc. were the passive bookrunners.
Proceeds will be used for general corporate purposes, including to refinance, redeem or repurchase existing debt and to repay a portion of commercial paper.
The biopharmaceutical company is based in New York.
Issuer: | Pfizer Inc.
|
Amount: | $5 billion
|
Description: | Senior notes
|
Active bookrunners: | BofA Merrill Lynch, Citigroup Global Markets Inc., Credit Suisse Securities (USA) LLC and Morgan Stanley & Co. LLC
|
Passive bookrunners: | Barclays, Goldman Sachs & Co. and HSBC Securities (USA) Inc.
|
Senior co-managers: | Deutsche Bank Securities Inc. and Santander Investment Securities Inc.
|
Co-managers: | Mizuho Securities USA Inc., RBC Capital Markets Corp., Academy Securities, Inc., Robert W. Baird & Co. Inc., Siebert Capital Markets and Williams Capital Group LP
|
Trade date: | Sept. 4
|
Settlement date: | Sept. 7
|
Ratings: | Moody’s: A1
|
| S&P: AA
|
| Fitch: A+
|
Distribution: | SEC registered
|
|
Three-year notes
|
Amount: | $1 billion
|
Maturity: | Sept. 15, 2021
|
Coupon: | 3%
|
Price: | 99.865
|
Yield: | 3.047%
|
Spread: | Treasuries plus 32 bps
|
Call: | Make-whole call at Treasuries plus 5 bps
|
|
Five-year floaters
|
Amount: | $300 million
|
Maturity: | Sept. 15, 2023
|
Coupon: | Libor plus 33 bps
|
Price: | Par
|
Call: | Non-callable
|
|
Five-year notes
|
Amount: | $1 billion
|
Maturity: | Sept. 15, 2023
|
Coupon: | 3.2%
|
Price: | 99.797
|
Yield: | 3.244%
|
Spread: | Treasuries plus 47 bps
|
Call: | Make-whole call at Treasuries plus 10 bps until Aug. 15, 2023, then a par call
|
|
10-year notes
|
Amount: | $1 billion
|
Maturity: | Sept. 15, 2028
|
Coupon: | 3.6%
|
Price: | 99.841
|
Yield: | 3.619%
|
Spread: | Treasuries plus 72 bps
|
Call: | Make-whole call at Treasuries plus 15 bps until June 15, 2028, then a par call
|
|
20-year notes
|
Amount: | $700 million
|
Maturity: | Sept. 15, 2038
|
Coupon: | 4.1%
|
Price: | 99.809
|
Yield: | 4.114%
|
Spread: | Treasuries plus 105 bps
|
Call: | Make-whole call at Treasuries plus 20 bps until March 15, 2038, then a par call
|
|
30-year notes
|
Amount: | $1 billion
|
Maturity: | Sept. 15, 2048
|
Coupon: | 4.2%
|
Price: | 99.762
|
Yield: | 4.214%
|
Spread: | Treasuries plus 115 bps
|
Call: | Make-whole call at Treasuries plus 20 bps until March 15, 2048, then a par call
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.